- Sun Pharma to acquire US oncology company for over Rs 3,000 crore The Times of India
- Sun Pharma to acquire Nasdaq-listed Checkpoint Therapeutics for $355 million or over Rs 3,000 crore Moneycontrol
- Indian Billionaire Dilip Shanghvi’s Sun Pharma To Buy U.S. Cancer Drug Maker For $355 Million Forbes
- Sun Pharma Shares Rise on Checkpoint Therapeutics Acquisition Rediffmail
- Sun Pharma to acquire Checkpoint Therapeutics for $355 million in cash and milestone payments CNBCTV18
Source: News feed